Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / VBIV - VBI Vaccines wins Health Canada approval for hepatitis B vaccine PreHevbrio

VBIV - VBI Vaccines wins Health Canada approval for hepatitis B vaccine PreHevbrio

VBI Vaccines Inc.

  • Health Canada has approved VBI Vaccines' ( NASDAQ: VBIV ) hepatitis B vaccine PreHevbrio .
  • The approval is the fourth for the triple-antigen shot.
  • Approval was based on data from two phase 3 trials that compared PreHevbrio to GlaxoSmithKline's ( GSK ) Engerix-B, a single-antigen vaccine. Results showed that those on PreHevbrio had statistically significant higher rates of seroprotection compared to the Engerix-B.
  • Seeking Alpha's Quant Rating views VBI Vaccines as a hold with high marks for growth and revisions .

For further details see:

VBI Vaccines wins Health Canada approval for hepatitis B vaccine PreHevbrio
Stock Information
Company Name: VBI Vaccines Inc.
Stock Symbol: VBIV
Market: NASDAQ
Website: vbivaccines.com
Menu
VBIV VBIV Quote VBIV Short VBIV News VBIV Articles VBIV Message Board
Get VBIV Alerts

News, Short Squeeze, Breakout and More Instantly...